Salicylic Acid (Page 2 of 2)

Pregnancy (Category C)

Salicylic acid has been shown to be teratogenic in rats and monkeys. It is difficult to extrapolate from oral doses of acetylsalicylic acid used in these studies to topical administration as the oral dose to monkeys may represent six times the maximal daily human dose of salicylic acid when applied topically over a large body surface. There are no adequate and well-controlled studies in pregnant women. Salicylic Acid 6% (w/w) Cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Nursing Mothers

Because of the potential for serious adverse reactions in nursing infants from the mother’s use of Salicylic Acid 6% (w/w) Cream, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. If used by nursing mothers, it should not be used on the chest area to avoid the accidental contamination of the child.

Carcinogenesis, Mutagenesis, Impairment of Fertility

No data is available concerning potential carcinogenic or reproductive effects of Salicylic Acid 6% (w/w) Cream. Salicylic acid has been shown to lack mutagenic potential in the Ames Salmonella test.

Adverse Reactions to Salicylic Acid

Excessive erythema and scaling conceivably could result from use on open skin lesions.

OVERDOSAGE

See WARNINGS.

DOSAGE AND ADMINISTRATION

The preferable method of use is to apply 6% Salicylic Acid (w/w) Cream thoroughly to the affected area and to cover the treated area at night after washing and before retiring. Preferably, the skin should be hydrated for at least five minutes prior to application. The medication is washed off in the morning and if excessive drying and/or irritation is observed, a bland cream or lotion may be applied. Once clearing is apparent, the occasional use of Salicylic Acid 6% (w/w) Cream will usually maintain the remission. In those areas where occlusion is difficult or impossible, application may be made more frequently; hydration by wet packs or baths prior to application apparently enhances the effect. (See WARNINGS.) Unless hands are being treated, hands should be rinsed thoroughly after application. Excessive repeated application of Salicylic Acid 6% (w/w) Cream will not necessarily increase its therapeutic benefit, but could result in increased local intolerance and systemic adverse effects such as salicylism.

HOW SUPPLIED

Salicylic Acid 6% (w/w) Cream Kit includes a 16 oz. (454 g) jar with Salicylic Acid 6% (w/w) Cream (NDC 42546-270-16) as well as a complimentary 12 fl. oz. PruDrate Hydrating Cleanser.

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

Do not freeze.

Manufactured for:
PruGen Pharmaceuticals
18899 N Thompson Peak Pkwy
Scottsdale, AZ 85255
Rev 3.0

PRINCIPAL DISPLAY PANEL — Kit Box

NDC 42546-270-01
Rx Only

Salicylic Acid
6% Cream
Kit

Dispense as a complete kit
For Topical Use Only

Kit includes:

  • 1 jar of Salicylic Acid 6% Cream
    — Net Wt. 16 oz (454 g)
  • 1 bottle PruDrate Hydrating Cleanser
    — 12 fl oz (355 mL)
  • Package Insert

PRUGEN ®
PHARMACEUTICALS

PRINCIPAL DISPLAY PANEL -- Kit Box
(click image for full-size original)
Established Pharmacological Class
Substance Pharmacological Class
PruDrate Hydrating Cleanser CLEANSING (COLD CREAMS, CLEANSING LOTIONS, LIQUIDS, AND PADS)
SALICYLIC ACID
salicylic acid kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42546-270
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:42546-270-01 1 KIT in 1 BOX None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 JAR 454 g
Part 2 1 BOTTLE 355 g
Part 1 of 2
SALICYLIC ACID
salicylic acid cream
Product Information
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SALICYLIC ACID (SALICYLIC ACID) SALICYLIC ACID 60 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
AMMONIUM LACTATE
CETOSTEARYL ALCOHOL
PEG-3 DISTEAROYLAMIDOETHYLMONIUM METHOSULFATE
POLYSORBATE 60
CETYL ALCOHOL
DIMETHICONE 350
EDETATE DISODIUM
GLYCERIN
GLYCERYL STEARATE SE
METHYLPARABEN
MINERAL OIL
PEG-100 STEARATE
PHENOXYETHANOL
PROPYLPARABEN
WATER
TROLAMINE
Product Characteristics
Color WHITE Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 454 g in 1 JAR None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 05/01/2011
Part 2 of 2
PRUDRATE HYDRATING CLEANSER
hydrating cleanser solution
Product Information
Route of Administration TOPICAL DEA Schedule
Ingredients
Ingredient Name Quantity
WATER
SODIUM LAURETH-3 SULFATE
COCAMIDOPROPYL BETAINE
GLYCERIN
COCO MONOETHANOLAMIDE
SODIUM LAUROYL SARCOSINATE
GLYCERYL MONOSTEARATE
PEG-100 STEARATE
CETYL ALCOHOL
JOJOBA OIL
POLYSORBATE 80
PHENOXYETHANOL
ETHYLHEXYLGLYCERIN
LEVOMENOL
MEDIUM-CHAIN TRIGLYCERIDES
XANTHAN GUM
SALICYLIC ACID
Packaging
# Item Code Package Description Multilevel Packaging
1 355 g in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
COSMETIC 05/01/2011
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 05/01/2011
Labeler — PruGen, Inc. (929922750)
Establishment
Name Address ID/FEI Operations
DERMAZONE SOLUTIONS, INC. 136116865 MANUFACTURE (42546-270)

Revised: 01/2022 PruGen, Inc.

Page 2 of 2 1 2

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.